Publication | Closed Access

Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy

Ugt2b7 H268yMedicinePharmacologyPathologyPharmacotherapyOpioid OverdoseCancer PatientsOncologyCancer ResearchOpioid Use DisorderChronic Morphine TherapyHealth Sciences